<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Maintaining Temperature Integrity in Direct-to-Patient Clinical Trials
Image Overlay - Maintaining Temperature Integrity in Direct-to-Patient Clinical Trials

Blog

Maintaining Temperature Integrity in Direct-to-Patient Clinical Trials

Maintaining Temperature Integrity in Direct-to-Patient Clinical Trials

Delivering to Patients—Without Compromising Control

As clinical trials shift toward decentralized models, Direct-to-Patient (DTP) delivery has become a critical component of modern trial design. Shipping investigational therapies directly to patients improves accessibility and engagement, but it also introduces new complexity, especially when managing temperature-sensitive products outside controlled environments.
At Yourway, DTP is not just an extension of logistics; it’s a specialized capability built on precision, coordination, and end-to-end control.

Why Temperature Integrity Matters More in DTP

Many investigational therapies, particularly biologics and cell and gene therapies—require strict temperature control to maintain stability and effectiveness.
Traditional supply chains rely on controlled environments like depots and clinical sites. DTP extends that chain into the last mile, where variability increases and risk must be actively managed.
Maintaining temperature integrity in this environment is essential to:

  • Protect product quality

  • Ensure regulatory compliance

  • Safeguard patient safety

The Complexity of Last-Mile Delivery

DTP introduces challenges that require more than standard logistics execution:

  • Uncontrolled environments: Deliveries extend beyond validated sites into real-world conditions

  • Patient coordination: Timing must align with patient availability to avoid delays

  • Extended transit windows: Packaging must perform reliably across variable durations 

  • Delivery precision: Routing and handoffs must be tightly managed to maintain conditions

This is where specialized DTP expertise becomes critical.

How Yourway Delivers DTP with Precision 

Yourway’s integrated model ensures temperature-sensitive therapies reach patients safely and reliably:

Validated Cold Chain Packaging
Qualified solutions across ambient, 2–8°C, frozen, and cryogenic ranges, designed for extended and variable transit conditions.

Real-Time Monitoring & Visibility
Continuous temperature tracking and shipment visibility to ensure compliance and enable proactive intervention.

Coordinated Patient Scheduling
Proactive communication and delivery window alignment to ensure successful first-attempt delivery.

End-to-End Supply Chain Control
From packaging and storage to global distribution and last-mile delivery, Yourway reduces handoffs and maintains consistency across every stage.

More Than Logistics—It’s Patient Impact

In DTP trials, every shipment directly impacts a patient. Reliable, temperature-controlled delivery ensures therapies arrive safe, effective, and ready for use—while reducing the burden of site visits.

Building Scalable DTP Programs

As decentralized trials continue to grow, DTP requires more than capability, it demands expertise, infrastructure, and coordination.

With Yourway’s fully integrated approach, sponsors gain:

  • Greater control across the supply chain 

  • Reduced risk in last-mile delivery 

  • Scalable solutions that support patient-centric trial models 

Because in Direct-to-Patient logistics, precision isn’t optional—it’s essential.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

GCSG 2026 US Conference

April 27-29, 2026
San Diego, CA

Pharma Supply Chain & Logistics Innovation Programme EU

May 20-21, 2026
Basel, Switzerland

Open chat
Come chat with us!
Hello! How can I help you?